DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group-Reference-Cited by-同舟云学术

DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group

Published:2022-10-19 Issue:3 Volume:131 Page:158-164
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Pierconti Francesco¹^ORCID,Rossi Esther Diana¹^ORCID,Cenci Tonia¹,Carlino Angela¹,Fiorentino Vincenzo¹,Totaro Angelo²,Sacco Emilio²,Palermo Giuseppe²,Iacovelli Roberto³,Larocca Luigi Maria⁴,Bassi Pier Francesco²,Martini Maurizio¹

Affiliation:

1. Institute of Pathology Universita Cattolica del S. Cuore‐Fondazione Policlinico A. Gemelli Rome Italy

2. Institute of Urology Universita Cattolica del S. Cuore‐Fondazione Policlinico A. Gemelli Rome Italy

3. Institute of Oncology Universita Cattolica del S. Cuore‐Fondazione Policlinico A. Gemelli Rome Italy

4. Institute of Pathology Universita UniCamillus‐Fondazione Policlinico A. Gemelli Rome Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22657

Reference18 articles.

1. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non–muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial

2. Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer

3. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples

4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result;Biomedicines;2023-12-12

2. Experiencia inicial y propuesta de seguimiento del tumor de vejiga no músculo infiltrante de alto riesgo mediante el uso de Bladder Epicheck®;Actas Urológicas Españolas;2023-10

3. Bladder Epicheck® for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience and follow-up proposal;Actas Urológicas Españolas (English Edition);2023-10

4. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples;International Journal of Molecular Sciences;2023-08-06

5. Large‐scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis‐X;Cancer Cytopathology;2023-06-28